Edition:
India

Viking Therapeutics Inc (VKTX.OQ)

VKTX.OQ on NASDAQ Stock Exchange Capital Market

4.74USD
30 Mar 2020
Change (% chg)

$0.21 (+4.64%)
Prev Close
$4.53
Open
$4.64
Day's High
$4.79
Day's Low
$4.48
Volume
342,267
Avg. Vol
360,629
52-wk High
$11.02
52-wk Low
$3.27

Latest Key Developments (Source: Significant Developments)

Viking Therapeutics Inc - On August 1, Entered Into An At-Market Equity Offering Sales Agreement
Friday, 2 Aug 2019 

Aug 2 (Reuters) - Viking Therapeutics Inc ::VIKING THERAPEUTICS INC - ON AUGUST 1, ENTERED INTO AN AT--MARKET EQUITY OFFERING SALES AGREEMENT.VIKING THERAPEUTICS INC - MAY OFFER AND SELL, FROM TIME TO TIME UP TO $75.0 MILLION SHARES OF ITS COMMON STOCK - SEC FILING.VIKING THERAPEUTICS INC - INTENDS TO USE ANY NET PROCEEDS FROM OFFERING FOR CONTINUED DEVELOPMENT OF ITS VK2809, VK0214 AND VK5211 PROGRAMS.  Full Article

Viking Therapeutics Posts Q2 LOSS PER SHARE Of $0.11
Friday, 2 Aug 2019 

Aug 1 (Reuters) - Viking Therapeutics Inc ::VIKING THERAPEUTICS REPORTS SECOND QUARTER 2019 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE.Q2 LOSS PER SHARE $0.11.Q2 EARNINGS PER SHARE ESTIMATE $-0.09 -- REFINITIV IBES DATA.  Full Article

Viking Therapeutics Q4 Loss Per Share $0.07
Thursday, 14 Mar 2019 

Viking Therapeutics Inc ::VIKING THERAPEUTICS REPORTS FOURTH QUARTER AND YEAR-END 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE.Q4 LOSS PER SHARE $0.07.Q4 EARNINGS PER SHARE ESTIMATE $-0.10 -- REFINITIV IBES DATA.YEAR-END CASH OF APPROXIMATELY $302 MILLION PROVIDES RUNWAY THROUGH AT LEAST 2021.INITIATION OF PHASE 2B STUDY OF VK2809 IN BIOPSY-CONFIRMED NASH PLANNED FOR 2H19.  Full Article

Viking Therapeutics Announces Pricing Of $175.8 Million Public Offering Of Common Stock
Friday, 21 Sep 2018 

Sept 20 (Reuters) - Viking Therapeutics Inc ::VIKING THERAPEUTICS ANNOUNCES PRICING OF $175.8 MILLION PUBLIC OFFERING OF COMMON STOCK.SAYS PUBLIC OFFERING OF 9.50 MILLION COMMON SHARES PRICED AT $18.50PER SHARE.  Full Article

Viking Therapeutics Announces Proposed Public Offering Of Common Stock
Thursday, 7 Jun 2018 

June 6 (Reuters) - Viking Therapeutics Inc ::VIKING THERAPEUTICS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK.VIKING THERAPEUTICS INC - INTENDS TO USE NET PROCEEDS FROM OFFERING FOR CONTINUED DEVELOPMENT OF ITS VK5211, VK2809 AND VK0214 PROGRAMS.  Full Article

BRIEF-Viking Therapeutics Reports Q4 And Year-End 2019 Financial Results

* VIKING THERAPEUTICS REPORTS FOURTH QUARTER AND YEAR-END 2019 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE